These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9136068

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Statistical comparison between dissolution profiles of drug products.
    Chow SC, Ki FY.
    J Biopharm Stat; 1997 May; 7(2):241-58. PubMed ID: 9136067
    [Abstract] [Full Text] [Related]

  • 4. An inferential procedure for the probability of passing the USP dissolution test.
    Chiang C, Chen CF, Huang MY, Liu JP.
    Pharm Stat; 2012 May; 11(1):32-8. PubMed ID: 21506255
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Dissolution Similarity Assessment Methods for Products with Large Variations: f2 Statistics and Model-Independent Multivariate Confidence Region Procedure for Dissolution Profiles of Multiple Oral Products.
    Yoshida H, Shibata H, Izutsu KI, Goda Y.
    Biol Pharm Bull; 2017 May; 40(5):722-725. PubMed ID: 28458360
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML, Berry MR, Nickerson B.
    J Pharm Biomed Anal; 2007 May 09; 44(1):79-84. PubMed ID: 17379465
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
    Kikuchi S, Takayama K.
    Int J Pharm; 2010 Feb 15; 386(1-2):149-55. PubMed ID: 19922778
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles.
    Maggio RM, Castellano PM, Kaufman TS.
    Eur J Pharm Sci; 2008 May 10; 34(1):66-77. PubMed ID: 18394869
    [Abstract] [Full Text] [Related]

  • 12. Statistical considerations in setting product specifications.
    Dong X, Tsong Y, Shen M.
    J Biopharm Stat; 2015 May 10; 25(2):280-94. PubMed ID: 25358110
    [Abstract] [Full Text] [Related]

  • 13. Assessment of similarity between dissolution profiles.
    Ma MC, Wang BB, Liu JP, Tsong Y.
    J Biopharm Stat; 2000 May 10; 10(2):229-49. PubMed ID: 10803727
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estimation of the probability of passing the USP dissolution test.
    Wang H.
    J Biopharm Stat; 2007 May 10; 17(3):407-13. PubMed ID: 17479390
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
    Novick S, Shen Y, Yang H, Peterson J, LeBlond D, Altan S.
    J Biopharm Stat; 2015 May 10; 25(2):351-71. PubMed ID: 25357203
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M.
    Biopharm Drug Dispos; 2004 Mar 10; 25(2):91-8. PubMed ID: 14872557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.